BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30555261)

  • 21. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.
    Liu D; Huang Y; Li L; Song J; Zhang L; Li W
    BMC Cancer; 2017 Dec; 17(1):882. PubMed ID: 29268698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 24. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.
    Käsmann L; Bolm L; Schild SE; Janssen S; Rades D
    Lung; 2017 Apr; 195(2):217-224. PubMed ID: 28154994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
    Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
    Wang C; Jin S; Xu S; Cao S
    Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.
    Huang W; Liu P; Zong M; Chen QQ; Zhou H; Kong H; Xie WP
    Cancer Manag Res; 2021; 13():4299-4307. PubMed ID: 34103985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas.
    Auezova R; Ryskeldiev N; Doskaliyev A; Kuanyshev Y; Zhetpisbaev B; Aldiyarova N; Ivanova N; Akshulakov S; Auezova L
    Onco Targets Ther; 2016; 9():6111-6117. PubMed ID: 27785058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab.
    Roussel E; Kinget L; Verbiest A; Debruyne PR; Baldewijns M; Van Poppel H; Albersen M; Beuselinck B
    Urol Oncol; 2021 Apr; 39(4):239.e17-239.e25. PubMed ID: 33485762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
    Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
    Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study.
    Zhou L; Xie Z; Shao Z; Chen W; Xie H; Cui X; Qin G; Zhao N
    J Thorac Dis; 2018 Feb; 10(2):1043-1049. PubMed ID: 29607179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients.
    Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
    BMC Cancer; 2022 Jan; 22(1):63. PubMed ID: 35027001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.
    Wang X; Teng F; Kong L; Yu J
    Onco Targets Ther; 2016; 9():5761-5770. PubMed ID: 27703374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis.
    Thompson JJ; McGovern J; Roxburgh CSD; Edwards J; Dolan RD; McMillan DC
    Crit Rev Oncol Hematol; 2024 Jul; 199():104378. PubMed ID: 38754770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer.
    Hong X; Cui B; Wang M; Yang Z; Wang L; Xu Q
    Tohoku J Exp Med; 2015 Aug; 236(4):297-304. PubMed ID: 26250537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.